複製鏈接
請複製以下鏈接發送給好友

彭英

(中山大學孫逸仙紀念醫院神經科主任醫師)

鎖定
彭英,博士,主任醫師,教授,博士生導師。現任中山大學孫逸仙紀念醫院神經科主任兼腦血管病專科主任,中國醫師協會腦與脊髓損害專委會主任委員,中國中西結合學會神經病分會常委,中國卒中學會卒中康復分會副主任委員,廣東省醫學會罕見病分會副主任委員,廣東省醫師協會神經病學分會副主任委員,廣東省中西結合學會神經病分會副主委,廣東省神經藥理學會副主任委員,世界華人生活質素學會常務委員,第四屆國際中毒性損傷會議組委會委員,第二屆國際神經病理性疼痛專家委員會委員。 [1-2] 
中文名
彭英
學    歷
博士
教學職稱
教授
臨牀職稱
主任醫師
執業地點
中山大學孫逸仙紀念醫院
專業方向
神經病學

彭英人物經歷

1997.11-2001.9:美國國立衞生研究院博士後
2000.4-2000.5:美國紐約冷泉港實驗室發育與功能基因培訓班學員
1989.9-1992.7:中山醫科大學神經病學博士研究生獲博士學位
1986.9-1989.7:第三軍醫大學神經病學碩士研究生獲碩士學位
1978.9-1983.7:湖南衡陽醫學院醫療係獲學士學位 [2] 

彭英研究方向

腦損傷機制及神經發育再生;
神經腫瘤及基因治療。 [1] 

彭英擅長領域

腦血管疾病、老年性和血管性痴呆、神經病理性疼痛、中毒性和放射性腦病的診治。 [2] 

彭英學術任職

中國醫師協會腦與脊髓損害專委會主任委員
中國中西結合學會神經病分會常委
中國卒中學會卒中康復分會副主任委員
廣東省醫學會罕見病分會副主任委員
廣東省醫師協會神經病學分會副主任委員
廣東省中西結合學會神經病分會副主任委員
廣東省神經藥理學會副主任委員
世界華人生活質素學會常務委員
第四屆國際中毒性損傷會議組委會委員
第二屆國際神經病理性疼痛專家委員會委員 [1] 

彭英雜誌編委

《中國神經精神疾病雜誌》副主編
《中山大學學報》醫學版編委
《中華腦科疾病與康復雜誌(電子版)》編委
《中國醫學與保健》編委
《中國神經再生雜誌》編委
《中華現代中西醫雜誌》編委
《國際腦血管病雜誌》編委
《中華現代影像學雜誌》常務編委
《國際神經病學神經外科雜誌》編委
《Journal of Cancer Metastasis and Treatment (JCMT)》Editor [1] 

彭英發表論文

以第一作者和通信作者發表文章:
1. Xiaoming Rong1, Bo Huang1, Shuwei Qiu2, Xiangpen Li1, Lei He1, Ying Peng*.Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation. Oncotarget. 2016; In press.(IF:5.02)
2. Yin Y, Fu C, Li M, Li X, Wang M, He L, Zhang LM, Peng Y*.A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment. Mater Sci Eng C Mater Biol Appl. 2016 Oct 1;67:159-69. doi: 10.1016/j.msec.2016.05.012.(IF:3.09)
3. Long X,Li Y, Qiu S, Liu J, He L, Peng Y*. MiR-582-5p/miR-590-5p targeted CREB1/CREB5-NF-κB signaling and caused opioid-induced immunosuppression in human monocytes.Transl Psychiatry. 2016 Mar 15;6:e757. doi: 10.1038/tp.2016.4. (IF:5.68)
4. Pan J, He L, Li X, Li M, Zhang X, Venesky J, Li Y, Peng Y*. Activating Autophagy in Hippocampal Cells Alleviates the Morphine-Induced Memory Impairment. Mol Neurobiol. 2016 Feb 13. [Epub ahead of print] (IF:5.397)
5. Pan J, Li X, Peng Y*.Remote ischemic conditioning for acute ischemic stroke:dawn in the darkness.Rev.Neurosci.2016 Jan19.pii: /j/revneuro.ahead-of-print/ revneuro -2015-0043/revneuro-2015-0043.xml. doi: 10.1515/revneuro-2015-0043. (IF:3.31)
6. Li H, Qiu S, Li X, Li M, Peng Y*.Autophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients. J Transl Med. 2015 Nov 14;13(1):359. doi: 10.1186/s12967-015-0726-3 (IF:3.93)
7. Yin Y, Qiu S, Peng Y*. Functional roles of enhancer of zeste homolog 2 in gliomas. Gene. 2015 Oct 13. pii: S0378-1119(15)01189-0. doi: 10.1016/j.gene.2015.09.080 (IF:2.138)
8. Huang D, Qiu S, Ge R, He L, Li M, Li Y, Peng Y*. MiR-340 suppresses glioblastoma multiforme. Oncotarget. 2015 Apr 20;6(11):9257-70.(IF:6.36)
9. Honghong Li, Lei He, Shuwei Qiu, Yi Li and Ying Peng*. Clinical Analysis in Chronic Alcoholic Encephalopathy: A Retrospective Study of 43 Subjects. Clinical Toxicology .2015; 5(2): 1-4
10. Peng Y*, Cooper SK, Li Y, Mei JM, Qiu S, Borchert GL, Donald SP, Kung HF, Phang JM*.Ornithine-a-aminotransferase inhibits neurogenesis during Xenopus embryonic development . Invest Ophthalmol Vis Sci. 2015 Mar 17. pii: IOVS-15-16509. doi: 10.1167/iovs.15-16509. [Epub ahead of print] (IF:3.6)
11. Yue PJ, He L, Shen QY, Qiu SW, Rong XM, Gong HX, Peng Y*. Long-term toxicity study of rAd5-hTERTC27 in SD rats and Cynomolgus monkeys by intravenous injection. Regul Toxicol Pharmacol. 2015 Mar;71(2):285-94. doi: 10.1016/j.yrtph.2014.12.022. Epub 2015 Jan 13.555PMID:25592546(IF:2.14)
12. Qiu S, Feng Y, LeSage G, Zhang Y, Stuart C, He L, Li Y, Caudle Y, Peng Y*, Yin D*.Chronic Morphine- Induced MicroRNA-124 Promotes Microglial Immunosuppression by ModulatingP65 and TRAF6. J Immunol. 2015 Feb 1;194(3):1021-30. doi: 10.4049/jimmunol.1400106. PMID:25539811 (IF:5.4)
13. Hu J, Li Y, Chen L, Yang Z, Zhao G, Wang Y, Cheng J, Zhao J, Peng Y*. Impact of IL-22 gene polymorphism on human immunodeficiency virus infection in Han Chinese patients.J Microbiol Immunol Infect. 2014 Nov 11. pii: S1684-1182(14)00226-6.doi:10.1016/j.jmii. 2014.09.002. (IF:2.35)
14. Wang Y, Li Y, Shen Q, Li X, Lu J, Li X, Yin D, Peng Y*.Valsartan blocked alcohol-induced, toll-like receptor 2 signaling-mediated inflammation in human vascular endothelial cells. Alcohol Clin Exp Res. 2014 Oct;38(10):2529-40. doi: 10.1111/acer.12532. (IF:3.31)
15. Wu Y, Peng Y*, Wang Y*.An insight into advances in the pathogenesis and therapeutic strategies of spinocerebellar ataxia type3. Rev Neurosci. 2014 Sep 12. pii: /j/revneuro ahead-of-print/revneuro- 2014-0040/revneuro-2014-0040.xml. doi: 10.1515/revneuro- 2014-0040. (IF:3.31)
16. Li XP, He L, Wang YD, Li Y, Li M, Peng Y*. Identification of Potential Biomarkers for Artificial Cold Exposure-induced Hypertensive Stroke by Proteomic Analysis. J Stroke Cerebrovasc Dis. 2014 Oct 9. pii: S1052-3057(14)00296-1.doi:10.1016/j.jstrokecerebrovasdis.2014.06.014.
17. Yue PJ, He L, Qiu SW, Li Y, Liao YJ, Li XP, Xie D, Peng Y*. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma. Mol Cancer. 2014 Aug 13;13(1):191. doi: 10.1186/1476-4598-13-191. (IF:5.88)
18. Chen S, Shen Q, Tang Y, He L, Li Y, Li H, Li M, Peng Y*. Efficacy and Safety of Adding Clopidogrel to Aspirin on Stroke Prevention among High Vascular Risk Patients: A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2014 Aug 11;9(8):e104402. doi: 10.1371/journal.pone.0104402. eCollection 2014. (IF:3.53)
19. Wang H, Tang Y, Rong X, Li H, Pan R, Wang Y, Peng Y*. Effects of early blood pressure lowering on early and long-term outcomes after acute stroke: an updated meta-analysis. PLoS One. 2014 May 22;9(5):e97917.doi: 10.1371/journal.pone.0097917. eCollection 2014 (IF:3.53)
20. Zheng D,Li Y, He L, Tang Y, Li X, Shen Q, Yin D, Peng Y*.The protective effect of astaxanthin on fetal alcohol spectrum disorder in mice. Neuropharmacology.2014 Apr 26; 84C:13-18. doi: 10.1016 /j.neuropharm. 2014.04.013. [Epub ahead of print] (IF:5.2)
21. Zheng D, Li Y, Liu Y, Rong X, Tang Y, Peng Y*, Shen Q*. Hypokalemia in Patients With Cough Mixture Abuse: A Retrospective Chart Review. J Addict Med. 2014 Apr 4. [Epub ahead of print] (IF:1.7)
22. Ling Long, Weiwei Wang, Xia‑Dong Cai, Du Cheng, Xintao Shuai and Ying Peng*. PinX1‑siRNA/ mPEG‑PEI‑SPION combined with doxorubicin enhances the inhibition of glioma growth. Experimental and Therapeutic Medicine. 2014; 7: 1170-1176 (IF:0.344)
23. Lu J, Luo H, Liu X,Peng Y*, Zhang B, Wang L, Xu X, Peng X, Li G, Tian W, He M, Hsiangfu K, Li X*. MiR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis. 2014 Mar;35(3):554-63.doi: 10.1093/carcin /bgt354 (IF:5.27)
24. Lu J, Xu X, Liu X, Peng Y*, Zhang B, Wang L, Luo H, Peng X, Li G, Tian W, He M, Li X*. Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis. Br J Cancer. 21;110(2):392-8. doi: 10.1038/bjc.2013.751.(IF:5.2)
25. Peng Y, Lu K, Li Z, Zhao Y, Wang Y, Hu B, Xu P, Shi X, Zhou B, Pennington M, Chandy KG, Tang Y*.Blockade of Kv1.3 channels ameliorates radiation-induced brain injury.Neuro Oncol. 2014 Apr;16(4):528-39. doi: 10.1093/neuonc/not221. Epub 2013 Dec 4.(IF:7.18)
26. Liu X, Luo HN, Tian WD, Lu J, Li G, Wang L, Zhang B, Liang BJ, Peng XH, Lin SX, Peng Y*, Li XP. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther. 2013 Aug 23;14(12). [Epub aheadof print] (IF:3.33)
27..He L, Li M, Long XH, Li XP, Peng Y*. A case of Hashimoto's encephalopathy misdiagnosed as viral encephalitis. Am J Case Rep. 2013 Sep 13;14:366-9. doi: 10.12659/AJCR.889312.
28.Lei He, Han-Xian Gong, Xiang-Pen Li, Yi-Dong Wang, Yi Li, Jun-Jian Huang, Dan Xie, Hsiang-Fu Kung and Ying Peng*. Inhibition of hepatocellular carcinoma growth by adenovirus‑mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice. Oncology Letters .2013; 6: 748-752,(IF:0237)
29.Yue PJ, He L, Li Y, Shen QY, Li M, Huang DQ, Huang JJ, Peng Y*. Preclinical Safety Evaluation of rAd5-hTERTC27 by intravenous injection. Regul Toxicol Pharmacol. 2013 Jul 1. pii: S0273-2300(13) 00099-8(IF:2.39)
30. Li C, Li X, Shen Q, Li Y, He L, Li M, Tang Y, Wang Y, He Q, Peng Y*.Critical Role of Matrix Metalloproteinase-9 in Acute Cold Exposure-Induced Stroke in Renovascular Hypertensive Rats. J Stroke Cerebrovasc Dis. 2013 Jun 22. doi:pii: S1052-3057(13)00183-3.(IF:1.98)
31. Qiu S, Huang D, Li F, Yin D, Kung HF, Peng Y*. Suppression of tumorigenicity by MicroRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme. BBA-MOL BASIS DISa. 2013 May 22;1832(10):1697-1707. (IF:5.23)
32. Qiu S, Lin S, Hu D, Feng Y, Tan Y, Peng Y*,Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. J Transl Med. 2013 Jan 9;11:10. doi: 10.1186/1479-5876-11-10.(IF:3.9)
33. Li H, Pan R, Wang H, Rong X, Yin Z, Milgrom DP, Shi X, Tang Y, Peng Y*. Clipping Versus Coiling for Ruptured Intracranial Aneurysms: A Systematic Review and Meta-Analysis. Stroke. 2013; 44(1):29-37(IF:6.83)
34. Kui Lu, Jue Wang, Bin Hu, Xiaolei Shi, Junyi Zhou, Yamei Tang , Ying Peng* Brilliant blue G attenuates lipolysaccharide- mediated microglial activation and inflammation. Neural Regeneration Research 2013; 8(7): 599-608(IF:0.144)
35. Liu X, Lu J, He ML, Li Z, Zhang B, Zhou LH, Li Q, Li G, Wang L, Tian WD, Peng Y, Li XP. Antitumor effects of interferon-alpha on cell growth and metastasis in human nasopharyngeal carcinoma. Curr Cancer Drug Targets. 2012 ;12(5):561-70.(IF:3.84)
36. Li D, Li XP, Wang HX, Shen QY, Li XP, Wen L, Qin XJ, Jia QL, Kung HF, Peng Y*. VEGF induces angiogenesis in a zebrafish embryo glioma model established by transplantation of human glioma cells. Oncol Rep. 2012; 28(3):937-42.(IF:2.297)
37. Gong HX, He L, Li XP, Wang YD, Li Y, Huang JJ, Wang Z, Xie D, Kung HF, Peng Y*. Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus. Oncol Rep. 2012 ;27(4):1163-9.(IF:2.297)
38. Yamei Tang, Xiangpen Li,Yi Li,Qingyu Shen, Xiaoming Rong, Ruxun Huang, Ying Peng*. Renovascular hypertension causes cerebral vascular remodeling. Neural Regeneration Research .2011; 6(25): 1977-1981(IF:0144)
39. He L, Li H, Chen L, Miao J, Jiang Y, Zhang Y, Xiao Z, Hanley G, Li Y, Zhang X, Lesage G, Peng Y*, Yin D*.Toll-like receptor 9 is required for opioid-induced microglia apoptosis. PLoS One. 2011 ; 29;6(4):e18190.(IF 4.41 )
40. Y. Tang, Q. Shen, Y. Wang, K. Lu, Y. Wang, Y. Peng*. A Randomized Prospective Study of Rehabilitation Therapy in the Treatment of Radiation-induced Dysphagia and Trismus. Strahlenther Onkol. 2011;187: 39-44 (IF 4.16 )
41. Kou Peng2, Yi Li1, Ling Long1, Dong Li2, Qiuli Jia2, Yidong Wang1, Qingyu Shen1, Yamei Tang1, Lu Wen2, Hsiang-fu Kung2, Ying Peng*, Knockdown of FoxO3a induces increased neuronal apoptosis during embryonic development in zebrafish. Neuroscience Lett 2010; 484(2):98-103 (IF 2.2 )
42. Ling Long, Yi Li, Yidong Wang, Qing Yu He, Mei Li, Xiao Dong Cai, Kou Peng, Xiang Pen Li, Dan Xie, Yan Ling Wen, De LingYin, and Ying Peng* .The preventive Effect of Oral EGCG ina Fetal Alcohol Spectrum disorder Mouse Model. Alcoholism: Clinical and Experimental Research 2010;34(11):1929-1936 (IF:3.4)
43. Dong Li,Kou Peng,Yi Li,Ying Peng*. Advancements on the Zebrafish of Glioma model. Chinese Journal of Cancer 2010; 29(6):621-5. (IF: 0.2)
44. Li Y, Li H, Zhang Y, Sun X, Hanley G, Zhang Y, Sun S, Peng Y*, and Yin D*. Toll-like receptor 2 is required for opioids-induced neuronal apoptosis. Biochem Biophys Res Commun. 2010, 391(1): 426-430. (IF:2.93)
45. Liang B, He ML, Chan CY, Chen YC, Li XP, Li Y, Zheng D, Lin MC, Kung HF, Shuai XT, Peng Y*. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat. Biomaterials 2009, 30(23-24):4014-4020.(IF:8.3)
46. Li Y, Sun Z, Zhang Y, Huang J, Hanley G, Ferslew K, Peng Y*, and Yin D. Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2. Biochem Biophys Res Commun. 2009, 378(4):857-861. (IF:2.93)
47. Liang B, He ML, Xiao ZP, Li Y, Chan CY, Kung HF, Shuai XT, Peng Y*. Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery. Biochem Biophys Res Commun. 2008, 367(4):874-880.(IF:2.93)
48. Ruiyan Lu, Qingyu Shen, Lianhong Yang, Mei Li, Yidong Wang, Ying Peng*. Effects of Kallikrein gene transfer on penumbral microvascular proliferation and regional cerebral blood flow following cerebral ischemia/reperfusion injury. Neural Regen Res 2008, 3:1045-50.
49. Ruiyan Lu, Lianhong Yang, Qingyu Shen, Mei Li, Xiangpen Li, Ying Peng*. Stereotaxic microinjection of adenovirus-mediated human tissue Kallilrein gene reduces apoptosis in a rat model of middle cerebral artery occlusion. Neural Regen Res 2008, 3: 847-52.
50. Li X, Liu X, Li C, Ding Y, Chau D, Li G, Kung HF, Lin M, and Peng Y*. Recombinant adeno-associated virus (rAAV) mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1. International Jorunal of Oncololgy 2006, 29(3):595-603.
51. Li X, Li C, Li X, Ding Y, Chan L, Yang P, Li G, Liu X , Lin J, Wang J, He M, Kung HF, Lin M and Peng Y*.Inhibition of Human Nasopharyngeal Carcinoma Growth and Metastasis in Mice by Adenovirus-associated Virus Mediated Expression of Human Endostatin. Molecular Cancer Therapeutics 2006, 5(5):1290-8.(IF:5.22)
52. Ying Peng, Pai-Hao Yang, Julian A.Tanner, Jian-Dong Huang, Ming Li, Henry F. Lee, Ren-He Xu, Hsiang-Fu Kung, and Marie C. Lin*. Cold-inducible RNA binding protein is required for expression of adhension molecules and embryonic cell movement and in Xenopus Laevis. B.B.R.C. 2006, 344(1): 416-426.
53. Ying Peng*, K-H Kwok, Pai-Hao Yang, Jie Liu, Ming-Liao He, Peter Fung, Hsiang-fu Kung and Marie C.M. Lin*. Ascorbic acid inhibits ROS production, NF-kappa B activation and prevents ethanol-induced growth retardation and microencephaly. Neuropharmacology 2005, 48: 426- 434.(IF:5.12) [3] 
54. Ying Peng, Pai-Hao Yang, K.H.H.Kwok, Yan Guo, Jie Liu, Ming-liang He,Samuel S.M.Ng, Jie Ge, Hsiang-fu kung and Marie C.M. Lin*. Protection of Xenopus Embryos Against Alcohol- induced Growth Retardation and Delayed gut Development by Peroxyredoxin. Journal of Molecular Biology 2004; 340: 819-27.(IF:5.02)
55. Ying Peng, Pai-hao Yang, Oscar G. Wong, Samuel S.M. Ng, Jie Liu, Ming-Liang He, Hsiang-fu Kung and Marie Lin*. A Critical Role of Pax6 in Alcohol-induced Fetal Microcephaly. Neurobiology of Disease 2004; 16 (2): 370-376.(IF:5.12)
56. Ying Peng. Bing-Hua Jiang, Pai-Hao Yang, Zongxian Cao, Xianglin Shi, Marie C.M. Lin, Ming-Liang He, and Hsiang-fu Kung*. Phosphatidylinositol-3 kinase signalings is involved in neurogenesis during Xenopus embryonic development. Journal of Biological Chemistry 2004;279(27):28509-14.(IF:6.35)
57.Ying Peng, Pai-Hao Yang, Yan Guo, Samuel S.M. Ng, Jie Liu, P.C. W. Fung, David Tay, Jian Ge, Ming-Liang He, Hsiang-fu Kung, and Marie. C. Lin*. Catalase and Peroxiredoxin 5 Protect Xenopus Embryos Against Alcohol-Induced Ocular Anomalies. Investigation Ophthalmology & Visual Science 2004; 45: 23-29 (IF: 3.93)
58. Xiang-Ping Li, Gang Li, Ying Peng, Hsiang-fu kung, and Marie C. Lin*. Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochemical and Biophysical Research Communications 2004; 315: 212-218 (Co-first author) (IF:2.904)
59. Ying Peng, Ren-He Xu, Jay Ming Mei, Xiang-Ping Li, Donghong Yan, Hsiang-fu Kung, James M. Phang*. Neural inhibition by c-Jun as a synergizing factor in BMP-4 signaling. Neuroscience 2002; 109(4): 657-664 (IF:3.456)
60. Ying Peng, K.H. Kok, Ren-He Xu, K.H.H. Kwok, P.C.W. Fung, Hsiang-fu Kung*, and Marie C.M. Lin. Maternal Cold Inducible RNA Binding Protein is required for Xenopus laevis Embryonic Development and kidney formation FEBS Letter 2000; 482: 37-43 (IF: 3.843) [1] 

彭英著作譯作

彭英主編專著

1、《腦梗死治療學》主編:彭英,王藝東,黃如訓。北京,人民衞生出版社。2010年3月
2、《中毒性腦病》主編:彭英。北京,人民衞生出版社。2011年8月
3、《放射性神經損傷》主編:唐亞梅,彭英。北京,人民衞生出版社。2012年7月

彭英參編專著

1、《腦卒中》主編:黃如訓,蘇鎮培 ;參編:彭英。北京,人民衞生出版社。2001年11月
2、《腦卒中》第二版,主編:黃如訓,蘇鎮培; 參編:彭英。北京,人民衞生出版社。2012年12月
3、《個體化醫學原則》主編:黃文林, 參編:彭英。北京,人民衞生出版社。2013年1月

彭英參編教材

1、《神經病學》國家衞生和計劃生育委員會“十二五” 規劃教材,第3版,主編:肖 波,參編:彭英。北京,人民衞生出版社。2013年1月
2、《神經病學》“十二五” 普通高等教育本科國家級規劃教材,中國高等教育學會醫學教育專業委員會規劃教材 第3版,主編:王擁軍 北京,參編:彭英。北京大學醫學出版社,2013年12月
3、《神經病學》國家醫學電子書包 ,主編:王擁軍 ,參編:彭英。北京,人民軍醫出版社,2016年

彭英獲獎情況

1、項目名稱:高血壓動脈硬化性腦梗死的病理機制及臨牀系列研究。廣東省科技進步二等獎,獲獎單位:中山醫科大學附屬第一醫院,第一軍醫大學南方醫院。1996年, 合作單位排名第一。
2、項目名稱:高血壓致腦血管損害及對梗塞影響的實驗研究。軍隊科技進步獎二等獎,獲獎單位:第一軍醫大學南方醫院。1997年,排名第一。
3、項目名稱:Neural inhibition by c-Jun as a synergizing factor in BMP-4 signaling. 美國國立衞生研究院傑出研究獎。 獲獎單位:美國國立衞生研究院國立癌症研究所基礎醫學實驗室,2001年。排名第一。
4、項目名稱:理化因素所致神經系統損傷的機制及干預。廣東省科技進步二等獎,獲獎單位:中山大學孫逸仙紀念醫院,2014年,排名第一。 [1] 

彭英主要學術成就

1、建立了多種酒精中毒性腦損傷小動物模型,發現了酒精所致神經發育障礙的關鍵靶基因,闡明瞭酒精緻腦損傷的過氧化物損傷機制。
2、發現Toll受體在腦卒中後的缺血性腦損傷中起重要作用,可作為缺血性腦損傷的干預靶點。
3、發明了一種既能夠通過血腦屏障又能靶向到膠質瘤的基因載體,動物實驗證明,其攜帶腫瘤抑制基因能明顯抑制膠質瘤的增值和生長。
在SCI雜誌發表論文99篇,總影響因子371.13分。以第一作者和通信作者發表論文60篇,其中影響因子5分以上文章17篇。單篇它引率最高55次。獲得國家級基金11項,省部基金15項,獲得美國發明專利和中國發明專利各一項。獲得軍隊科技進步二等獎一項,廣東省科技進步二等獎二項。 [1] 

彭英科研項目

彭英國家級項目

1. 國家自然科學基金:神經發生啓動基因的分離(1997-2000)項目編號:39870207,項目經費:13萬,主持。
2. 國家自然科學基金:ARF6基因在神經發育中的功能作用及與P13K的相互關係(2005-2007)項目編號:30570589,項目經費:10萬,主持。
3. 國家自然科學基金:修飾型PPE-EA介導caspase-8CD基因聯合治療神經膠質瘤的研究(2007-2009)項目編號:30672411項目經費:28萬,主持。
4. 863重點項目課題:利用hTERTC27多肽基金病毒疫苗抗癌的治療研究(2008-2012)項目編號:2007AA021101,項目經費:390萬,主持。
5. 國家“十一五”科技支撐計劃重大項目分題:缺血中風綜合防治方案和療效評價的示範研究(2007-2009)項目編號:2006BA104A02,項目經費:4萬, 主持。
6. 國家自然科學基金:TfR抗體和CTX修飾納米載體介導hTERTC27治療神經膠質瘤(2010-2012)項目編號:30973479,項目經費:32萬,主持。
7. 國家自然科學基金:Foxo3a在神經發育過程的功能作用及信號傳導(2011-2013)項目編號:31070953,項目經費:35萬, 主持。
8. 國家“十二五”科技支撐計劃課題分題:腦血管病整體康復適宜技術的開發推廣及康復信息平台的建設(2012-2015)項目編號:2011BAI08B11 ,項目經費:3.5萬, 主持。
9. 國家自然科學基金:EZH2信號環路的相互作用及對神經膠質瘤細胞週期、增殖與侵襲的影響(2013-2016)項目編號:81272197,項目經費:70萬,主持。
10. 國家自然科學基金海外和港澳合作基金:TLR2介導小膠質細胞激活在嗎啡依賴中的作用(2013-2014)項目編號:81228010,項目經費:20萬,主持。
11. 國家自然科學基金:IL-6家族與miR-340交互負反饋調控膠質瘤免疫抑制的功能與機制研究 (2016-2019) 項目編號:81572481, 項目經費:60萬,主持。
12. 國家自然科學基金重點課題培育項目:miR-7在神經膠質瘤轉移的作用機制及靶向干預的新策略(2011-2013)項目編號:10ykjc26,項目經費:20萬,主持。 [1] 
參考資料